Alnylam Pharmaceuticals
ALNY
#574
Rank
$43.62 B
Marketcap
$328.95
Share price
-1.19%
Change (1 day)
35.08%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company